Published in

American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(36), p. 2549-2549

DOI: 10.1200/jco.2018.36.15_suppl.2549

Links

Tools

Export citation

Search in Google Scholar

Phase I trial of the triplet M6620 (formerly VX970) + veliparib + cisplatin in patients with advanced solid tumors.

Journal article published in 2018 by Geraldine Helen O'Sullivan Coyne, Khanh Tu Do, Shivaani Kummar, Naoko Takebe, Mary Flanagan Quinn, Sarina Anne Piha-Paul, Ashley Bruns, Lamin Juwara, Elad Sharon, Richard Piekarz, Howard Streicher, Larry Rubinstein, Deborah Wilsker, Robert J. Kinders, Ralph E. Parchment and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO